• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰营养监督治理:报告未注册产品的不良事件。

Governance of nutrivigilance in the Netherlands: Reporting adverse events of non-registered products.

机构信息

Food Claims Centre Venlo, Campus Venlo, Maastricht University, P.O. Box 8, Venlo 5900 AA, the Netherlands.

Food Claims Centre Venlo, Campus Venlo, Maastricht University, P.O. Box 8, Venlo 5900 AA, the Netherlands.

出版信息

Health Policy. 2022 Aug;126(8):731-737. doi: 10.1016/j.healthpol.2022.05.011. Epub 2022 May 23.

DOI:10.1016/j.healthpol.2022.05.011
PMID:35643570
Abstract

The Dutch Pharmacovigilance Centre Lareb receives an increasing number of reports on products that fall within the grey area of non-registered health-enhancing products, including supplements. Currently, there is no structural vigilance approach to handling these spontaneous reports of suspected adverse events. This explorative study identified whether and how a vigilance framework in the Netherlands can be organised to contribute to consumer protection from adverse reactions to health-enhancing food products. Conducted interviews showed that involved organisations form a complex network, without official governance structures. Organisations lack a legal basis to handling reports, whilst representatives do feel the need to take reports seriously. Interviewees identified various opportunities to improve vigilance, including raising consumer awareness. Following our study, first steps were taken towards improving safety by officially designating Lareb to study adverse events. Further advances to food supplement safety were announced by the Dutch Ministry but have not yet been implemented. With highly differing approaches to governing vigilance in- and outside the EU, it remains necessary to further analyse how nutrivigilance can be organised best to stimulate consumer protection from unsafe substances.

摘要

荷兰药品监测中心 Lareb 收到越来越多关于处于非注册健康增强产品灰色地带的产品的报告,包括补充剂。目前,对于这些可疑不良事件的自发报告,没有结构监测方法来处理。这项探索性研究确定了荷兰是否可以组织一个监测框架,以防止消费者因食用健康增强食品而产生不良反应。进行的访谈表明,相关组织形成了一个复杂的网络,没有正式的治理结构。组织缺乏处理报告的法律依据,而代表们确实认为有必要认真对待报告。受访者确定了各种改进监测的机会,包括提高消费者的意识。在我们的研究之后,Lareb 被正式指定研究不良事件,这是朝着提高安全性迈出的第一步。荷兰卫生部宣布了进一步提高食品补充剂安全性的措施,但尚未实施。由于在欧盟内外对监测的治理方法存在很大差异,因此仍有必要进一步分析如何最好地组织营养监测,以刺激消费者免受不安全物质的侵害。

相似文献

1
Governance of nutrivigilance in the Netherlands: Reporting adverse events of non-registered products.荷兰营养监督治理:报告未注册产品的不良事件。
Health Policy. 2022 Aug;126(8):731-737. doi: 10.1016/j.healthpol.2022.05.011. Epub 2022 May 23.
2
Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb.荷兰国家药物警戒中心 Lareb 收到的与草药药品和草药补充剂相关的药物不良反应报告分析。
Drug Saf. 2022 Jun;45(6):651-661. doi: 10.1007/s40264-022-01180-5. Epub 2022 May 24.
3
Adverse food-drug interactions.不良食物-药物相互作用。
Regul Toxicol Pharmacol. 2015 Dec;73(3):859-65. doi: 10.1016/j.yrtph.2015.10.009. Epub 2015 Oct 19.
4
Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb.红曲米(紫红曲霉)补充剂:向荷兰药物警戒中心 Lareb 自发报告病例的病例系列评估。
Br J Clin Pharmacol. 2021 Apr;87(4):2146-2151. doi: 10.1111/bcp.14599. Epub 2020 Nov 18.
5
Fifteen years of patient reporting -what have we learned and where are we heading to?十五年的患者报告——我们学到了什么,未来的方向在哪里?
Expert Opin Drug Saf. 2019 Jun;18(6):477-484. doi: 10.1080/14740338.2019.1613373. Epub 2019 May 16.
6
Actions in response to drug safety signals arising from a spontaneous reporting system: Retrospective study in The Netherlands.针对自发报告系统产生的药物安全信号所采取的行动:荷兰的回顾性研究
Int J Risk Saf Med. 2016 Aug 22;28(2):115-23. doi: 10.3233/JRS-160724.
7
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems.通过自发报告系统评估含α-硫辛酸的膳食补充剂的不良反应。
Clin Nutr. 2021 Mar;40(3):1176-1185. doi: 10.1016/j.clnu.2020.07.028. Epub 2020 Jul 29.
8
Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods.全科医生药物警戒培训效果的比较:荷兰的一项回顾性队列研究比较了两种方法。
Drug Saf. 2011 Sep 1;34(9):755-62. doi: 10.2165/11592800-000000000-00000.
9
[Phytovigilance: A medical requirement and a legal obligation].[植物药警戒:一项医学要求与法律义务]
Ann Pharm Fr. 2016 Jan;74(1):49-60. doi: 10.1016/j.pharma.2015.06.004. Epub 2015 Jul 22.
10
Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.使用 VigiBase 在协作信号检测研讨会上报告的患者报告的安全问题:Lareb 和 Uppsala 监测中心的结果和反思。
Drug Saf. 2018 Feb;41(2):203-212. doi: 10.1007/s40264-017-0594-2.

引用本文的文献

1
Protein and Amino Acid Supplementation Among Recreational Gym Goers and Associated Factors-An Exploratory Study.休闲健身者的蛋白质和氨基酸补充情况及相关因素——一项探索性研究
J Funct Morphol Kinesiol. 2025 Jun 28;10(3):248. doi: 10.3390/jfmk10030248.
2
Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy.监管行动对维生素B6膳食补充剂剂量最大化的影响及其对神经病变报告模式的作用。
Pharmacoepidemiol Drug Saf. 2025 Feb;34(2):e70108. doi: 10.1002/pds.70108.
3
Qualitative Interviews with Stakeholders in Herbal Pharmacovigilance and Recommendations for Best Practices to be Applied Worldwide.
对草药药物警戒利益相关者的定性访谈及适用于全球的最佳实践建议
Drug Saf. 2025 Jan;48(1):75-86. doi: 10.1007/s40264-024-01480-y. Epub 2024 Sep 12.
4
Nutrivigilance: the road less traveled.营养警戒:鲜有人走的路。
Front Pharmacol. 2023 Oct 11;14:1274810. doi: 10.3389/fphar.2023.1274810. eCollection 2023.
5
Identifying Crude Drugs in Kampo Medicines Associated with Drug-Induced Liver Injury Using the Japanese Adverse Drug Event Report Database: A Comprehensive Survey.利用日本药品不良事件报告数据库识别与药物性肝损伤相关的汉方药中的生药:一项综合调查。
Pharmaceuticals (Basel). 2023 May 1;16(5):678. doi: 10.3390/ph16050678.